SCHEMBL13147635

SCHEMBL13147635

Cc1cn(C2CCC2)c2ncc(Br)cc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTR6 P50406 3/20 0.32
OPRK1 P41145 2/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
BRD4 O60885 2/20 0.31
SCN5A Q14524 1/20 0.31
SCN9A Q15858 1/20 0.31
SRC P12931 3/20 0.31
ABL1 P00519 2/20 0.31
EGFR P00533 2/20 0.31
ABL2 P42684 2/20 0.31
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31403600 0.82 ADORA2A (0.36) PDE4APDE4BPDE4CPDE4DSRC
SCHEMBL586526 0.79 XDH (0.39) ABL1RET
SCHEMBL31403567 0.78 HSD17B10 (0.40) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL31403505 0.78 MAPT (0.39) PDE4APDE4BPDE4CPDE4DOPRK1
SCHEMBL31403718 0.75 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DL3MBTL1
SCHEMBL25386480 0.74 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DOPRK1
SCHEMBL14884084 0.73 HSD17B10 (0.43) HSD17B10L3MBTL1BRD4ABL1RET
SCHEMBL18892022 0.71 HSD17B10 (0.39) HSD17B10L3MBTL1ABL1RETKDM4E
SCHEMBL22533181 0.70 BRD4 (0.38) PDE4DOPRK1BRD4SRCRET
SCHEMBL31386207 0.70 ATM (0.35) HSD17B10OPRK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010117935-A1 COMPOUNDS AND METHODS FOR ANTIVIRAL TREATMENT SCHERING CORPORATION (US) 2010-10-14 WO disclosed